Participants in higher quartiles of AIP tended to be male, elder and were more likely to have a higher BMI, SBP, DBP liver enzymes (including ALP, GGT, ALT, AST), CR, UA, blood lipids (including TC, TG, HDL-C, LDL-C), fasting triglycerides, glucose, and NAFLD risk than in lower quartiles. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.